The mechanisms utilized to transduce apoptotic signals that originate from within the nucleus, in response to DNA damage for example, are not well understood. Identifying these mechanisms is important for predicting how tumor cells will respond to genotoxic radiation or chemotherapy. The Rb tumor suppressor protein can inhibit apoptosis triggered by DNA damage, but how it does so is unclear. We have previously characterized a death domain protein, p84N5, that specifically associates with an amino-terminal domain of Rb protein. The p84N5 death domain is required for its ability to trigger apoptotic cell death. Association with Rb protein inhibits p84N5-induced apoptosis suggesting that it may be a mediator of Rb's effects on apoptosis. Unlike other death domain-containing apoptotic signaling proteins, however, p84N5 is localized predominantly within the nucleus of interphase cells. Here we test whether p84N5 requires nuclear localization in order to trigger apoptosis. We identify the p84N5 nuclear localization signal and demonstrate that nuclear localization is required for p84N5-induced apoptosis. To our knowledge, this identifies p84N5 as the first death-domain containing apoptotic signaling protein that functions within the nucleus. By analogy to other death domain containing proteins, p84N5 may play some role in apoptotic signaling within the nucleus. Further, p84N5 is a potential mediator of Rb protein's effects on DNA damage induced apoptosis.
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The signal transduction pathways culminating in apoptosis in response to extracellular stimuli, like tumor necrosis factor, or in response to mitochondrial signals, such as cytochrome c release, are well characterized (Wolf and Green, 1999; Yuan, 1997) . Initiator caspases are typically recruited to protein complexes composed of death receptors and/or adapter molecules. These proteins contain signature protein interaction motifs like the death domain, the death effector domain, or the CARD domain. Complex formation leads to the activation of caspases that are required for execution of the apoptotic program. Apoptotic signals can also originate from within the nucleus. For example, DNA damage caused by radiation triggers a stress response from within the nucleus that results in apoptotic cell death (Haimovitz-Friedman, 1998) . The mechanisms utilized by nuclear signals to initiate apoptosis are not well understood.
Few proteins are documented to require nuclear localization in order to function in an apoptotic response. Hence mechanisms for transducing apoptotic signals that originate from within the nucleus have not been identified. Some transcription factors can induce apoptosis, including p53 (Sheikh and Fornace, 2000; Sionov and Haupt, 1999) . Although p53 is presumed to trigger apoptosis from within the nucleus by altering the expression of genes (Yin et al., 1997) , non-nuclear mechanisms unrelated to transcriptional regulation have also been proposed (Bennett et al., 1998) . Expanded polyglutamine repeat proteins require nuclear localization for their ability to induce the apoptosis that causes Huntington's disease or spinocerebellar ataxia (Klement et al., 1998; Saudou et al., 1998) . Activation of caspase-8 is a required step in this process (Sanchez et al., 1999) and is accomplished by recruitment of the proenzyme to characteristic nuclear protein aggregates that are associated with these diseases.
The nuclear retinoblastoma tumor suppressor protein (Rb) can inhibit apoptosis initiated by a number of agents (Wang, 1997) , including DNA damage (Haas-Kogan et al., 1995) . How Rb regulates apoptosis and whether this function is independent of its ability to regulate the cell cycle is unknown. However, amino-terminal deleted Rb mutants, which retain sequences that are sufficient to regulate the cell cycle in vitro, are unable to restore normal apoptosis in Rb7/7 mice (Riley et al., 1997) . The N5 cDNA was originally isolated based on the ability of its encoded protein (p84N5) to bind the amino-terminal domain of Rb (Durfee et al., 1994) . The predicted primary sequence of p84N5 has significant similarity to the death domains found in proteins important for death receptor apoptotic signaling (Feinstein et al., 1995) . Ectopic expression of p84N5 can trigger p53-indepen-dent apoptosis (Doostzadeh-Cizeron et al., 1999) . Characteristic death domain point mutations that compromise the function of other death domain containing proteins also compromise the ability of p84N5 to induce apoptosis. Association with Rb protein can inhibit p84N5-induced apoptosis. Although an amino-terminal Rb mutant can regulate the cell cycle, it is unable to associate with p84N5 nor can it inhibit p84N5-induced apoptosis. These findings suggest that p84N5 may mediate Rb protein's effects on apoptosis and that these effects are independent of its ability to regulate the cell cycle. Further, by analogy to other death domain containing proteins p84N5 may play some role in transducing apoptotic signals generated from within the nucleus.
A key prediction of this hypothesis is that p84N5 triggers apoptosis from within the nucleus. In the present study we have tested this prediction by identifying the p84N5 nuclear localization signal and determining whether nuclear localization is required for p84N5-induced cell death. To facilitate identifying the p84N5 nuclear localization signal (NLS), we subcloned the near full-length N5 cDNA into EGFP-C1 to create a plasmid designed to express a GFPN5 fusion protein. This fluorescent protein contains GFP fused to the amino-terminus of p84N5 amino acids 52 to 657 (Figure 1b ). Following transfection of GFPN5 into SAOS-2 cells, 10 -15% of the cells exhibited a fluorescent signal and this signal was localized exclusively within the nucleus ( Figure 1a ). In contrast, cells transfected with EGFP-C1 exhibit fluorescence throughout the cell. Although the GFPN5 fusion protein is correctly localized to the nucleus, it does not exhibit the punctate staining pattern typically observed upon immunofluorescent staining of endogenous p84N5 (Durfee et al., 1994) . This is likely due to the fact that the GFPN5 protein accumulates to higher levels than the endogenous protein (data not shown). A small fraction of GFPN5 positive cells, less than 5%, show green fluorescence outside the nucleus. Based on their morphology, these cells may be undergoing apoptosis; localization of endogenous p84N5 has been observed to change during apoptosis (Doostzadeh-Cizeron et al., 1999) .
A series of deletions within the N5 coding region of GFPN5 were created, expressed, and analysed for nuclear localization by microscopy ( Figure 1b) . A deletion mutant lacking p84N5 amino acids 318 to 657 (GFPN5SB) expressed a fluorescent signal throughout the cell while a mutant lacking amino acids 464 to 657 (GFPN5EB) expressed a protein localized within the nucleus (Figure 1a ). Hence the p84N5 NLS was likely located within amino acids 318 to 464. The GFPN5SE mutant that expresses a nuclear localized protein containing only amino acids 318 to 464 confirmed this. Western blot analysis of protein extracts from similarly transfected cells using an anti-GFP antibody indicated that each plasmid expressed a protein of the expected apparent molecular mass (Figure 1c ).
Amino acids 318 to 464 of p84N5 contain a potential bipartite NLS with the sequence RKRTA-PEDFLGKGPTKK that spans amino acids 414 to 430 (Figure 2b ). To test whether this sequence is necessary and sufficient for localizing GFPN5 to the nucleus, we constructed an additional series of mutants Figure 1 Mapping of amino acids required for exclusive nuclear localization of p84N5. (a) SAOS-2 cells were transfected with the indicated plasmid DNA using the calcium phosphate precipitation method (Wigler et al., 1979) . Cells were plated on etched coverslips one day prior to transfection. One day post-transfection, coverslips were washed twice in phosphate-buffered saline (PBS) and fixed in a solution containing 1% paraformaldehyde in PBS. Fixed cells were washed twice with PBS and once with distilled water before mounting on slides. Images were captured under fluorescent microscopy using the indicated filter with a Hamamatsu 16-bit digital camera mounted on a Zeiss Axioplan microscope using a 636 objective. Images shown are representative of multiple cells for each transfection examined. (b) An 1800 bp fragment encoding amino acids 54 to 656 of the p84N5 cDNA was subcloned in frame into the EGFP-C1 mammalian expression vector to create GFPN5. Subsequent deletion mutants were derived from this construct as follows: GFPN5NB was created by deleting the NheI -BamHI fragment of GFPN5; GFPN5EB was created by deleting the EcoRI -BamHI fragment of GFPN5; GFPN5SB was created by deleting the SalI -BamHI fragment of GFPN5; GFPN5SE is an inframe internal deletion created from GFPN5EB by removing the SalI -EcoRI fragment and inserting a SpeI linker. GFP is expressed from the empty EGFP-C1 plasmid. The schematic indicates the p84N5 amino acids included within each plasmid, the position of the p84N5 death domain, and whether the expressed fusion protein is localized predominantly within the nucleus. (c) For protein expression analysis, the 293 cell line was transfected as above and 2 days later resuspended in an ice-cold buffer containing 50 mM Tris, pH 7.4, 250 mM NaCl, 5 mM EDTA, 0.1% NP-40, 50 mM Naf, 1 mM PMSF, 1 mg/ml leupeptin. Protein was extracted by three rounds of freeze/thaw and ell debris was pelleted by microcentrifugation. Total protein concentration of the soluble extract was determined by Bradford assay according to the manufacturer's instructions (BioRad, Hercules, CA, USA). Twenty mg of total soluble protein for each sample was resolved by SDS -PAGE on a 10% gel. The proteins were transferred to nitrocellulose and stained for the fusion proteins using an anti-GFP antibody (Clontech, Palo Alto, CA, USA) or b-actin as previously described (Doostzadeh-Cizeron et al., 2000) . Primary antibody was detected using a peroxidase-conjugated secondary antibody and Enhanced Chemiluminescence as described by the manufacturer (Amersham Pharmacia Biotech, Uppsala, Sweden). The position of molecular weight standards is indicated on the left containing alterations within this sequence. GFPN5-NLS is an in-frame deletion of sequences encoding amino acids 414 to 430. GFPN5NES replaces these sequences with amino acids that are similar to the nuclear export signal (NES) of HIV-1 Rev (Fischer et al., 1995) . Both of these mutants expressed a fluorescent protein that failed to localize within the nucleus (Figure 2a) . The distribution of GFP signal from these mutants between the nucleus and the cytoplasm varied from cell to cell. In some cells (as in Figure 2a ) there appeared to be little nuclear signal. In other cells, however, the signal appeared to be uniformly distributed throughout the cells (similar to GFP in Figure 2a) . Although GFPN5NES contained an NES, it failed to exclude GFP signal from the nucleus to any greater extent than the GFPN5-NLS mutant. Replacing p84N5 amino acids 414 to 430 with an unrelated NLS (RYAQEMEGEEEA) restored nuclear localization of the fusion protein expressed from the GFPN5hNLS mutant. A GFP fusion protein expressed from the GFPNLS mutant containing just N5 amino acids 414 to 430 was also localized exclusively to the nucleus. The fusion proteins expressed by all of the mutant plasmids were analysed by Western blotting of total protein extracted from similarly transfected cells. All of the plasmids expressed a fusion protein of predicted molecular mass confirming that the correct protein was made in each case (Figure 2c) . We conclude that amino acids 414 to 430 contain the sequence that is both necessary and sufficient to localize p84N5 to the nucleus.
Expression of p84N5 in detectable C33-A cells induced apoptotic cell death by annexin V staining (Doostzadeh-Cizeron et al., 2000) . To test the function of GFPN5 and the mutant derivatives, we analysed their ability to trigger apoptosis upon expression in C33-A cells. Annexin V staining was detected in about 40% of cells successfully transfected with GFPN5 compared to less than 10% of cells expressing the negative control proteins GFP or GFPNLS (Figure 3 ). Both mutant fusion proteins that failed to localize within the nucleus, GFPN5-NLS and GFPN5NES, had reduced ability to trigger apoptosis as indicated by annexin V staining on only about 15% of successfully transfected cells. Restoration of nuclear localization with the unrelated NLS in the GFPN5hNLS fusion protein also restored its ability to trigger annexin V staining in a percentage of cells comparable to that observed with wild type GFPN5. Each of the GFPN5 fusion proteins accumulated to approximately the same level (Figure 2c ). The differences in function observed for the mutant fusion proteins, therefore, was not due to differences in protein level. The mutant plasmids were constructed by PCR-mutagenesis as previously described (Fisher and Pei, 1997) . The template for mutagenesis was GFPN5. GFPN5-NLS was created using the following pair of adjacent phosphorylated primers (5'-AATTATTCTCGTAGGTTTGGTA-TCTGATG-3' and 5'-ATTCTGACGGGAAATGAGGAGTTA-ACAAGG-3'). GFPN5+NLS was created using the following pair of adjacent phosphorylated primers (5'-CATCTCCTGGGCAT-AACGAATTATTCTCGTAGGTTTGGTATC-3' and 5'-GAA-GGCGAAGAAGAAGCCAT TCTGACGGGAAAT GAGGAG-TTA-3'). GFPN5+NES was created using the following pair of adjacent phosphorylated primers (5'-GAACTTCTTCGTCATA-ATTATTCTCGTAGGTTTGGTATC-3' and 5'-GGCACGCTC-ACGATCATTCTGACGGGAAATGAGGAG-3'). DNA sequencing was used to confirm the mutagenesis. The schematic indicates the amino acid sequence of the putative bipartite p84N5 NLS, the amino acids contained in the mutant derivatives, and whether they are localized predominantly within the nucleus. (c) Total cell protein extracted from 293 cells transfected with each of the indicated plasmid constructs was analysed by Western blotting as in Figure  1 . The position of molecular weight standards is indicated on the left Figure 3 Nuclear localization is required for N5-induced apoptosis. C33-A cells were analysed for apoptosis by annexin V staining upon expression of the indicated fusion proteins. Cells were seeded in 10 cm dishes at 25% confluency and transfected the following day as in Figure 1 . Thirty-six hours after transfection cells were harvested by trypsinization, washed with PBS, and stained with Annexin V-R-PE as per the manufacturer's instructions (Caltag Laboratories, Burlingame, CA, USA). FACS analysis was performed on a FACSCalibur instrument (Becton Dickinson, San Jose, CA, USA). Successfully transfected cells were gated based on GFP fluorescence and the percentage of these cells positive for annexin V determined using the PE channel. In parallel experiments under the same experimental conditions, the percentage of late apoptotic or necrotic cells as determined by propidium iodide staining was typically less than 5%. The data shown are the mean and standard deviation of at least three transfections Since expression of p84N5 can induce a G2/M cell cycle arrest (Doostzadeh-Cizeron et al., 2001) as well as apoptosis, p84N5 can reduce the proliferative capacity of cells (Doostzadeh-Cizeron et al., 1999) by multiple mechanisms. To exclude the possibility that the failure of the GFPN5-NLS or GFPN5NES proteins to trigger apoptosis was merely due to a delay in the kinetics of apoptosis, we have tested their ability to reduce the clonogenic potential of cells. As expected, cells expressing GFPN5 have at least a fivefold decrease in their ability to form proliferating colonies compared to cells expressing GFP (Figure 4) . Cells expressing either the GFPN5-NLS or GFPN5NES fusion proteins are able to form proliferating colonies with 3 -4-fold greater efficiency than cells expressing GFPN5. Restoration of nuclear localization in the GFPN5hNLS mutant restores the ability of the fusion protein to reduce the clonogenic potential of expressing cells to levels similar to that observed with wild type GFPN5.
Cells expressing mutant proteins that did not localize to the nucleus, GFPN5-NLS and GFPN5NES, have a lower percentage of apoptotic cells and greater clonogenic potential than cells expressing wild type GFPN5. Although cells expressing GFPN5-NLS or GFPN5NES are both compromised in their function, they do demonstrate activity in these assays above the negative controls GFP and GFPNLS. This is likely due to the fact that some protein makes it into the nucleus in some transfected cells. The relative level of nuclear fluorescence observed in cells expressing GFPN5-NLS and GFPN5NES proteins varies from cell to cell. Some cells appear to have a uniform distribution of protein throughout the cell, including the nucleus (similar to GFP in Figure 2a ). Other cells appear to have very little protein within the nucleus (similar to GFPN5-NLS or GFPN5NES in Figure 2a ). Although these mutant proteins are not localized predominantly within the nucleus, neither are they excluded from the nucleus. There is no consistent difference in the relative amount of nuclear fluorescence observed between any of the mutant proteins or GFP even though GFPN5NES contains an NES. Hence some cells expressing GFPN5-NLS or GFPN5NES may accumulate sufficient nuclear protein to induce cell cycle arrest and apoptosis in the absence of an NLS. This may explain their reduced, but detectable, level of activity in these assays.
We conclude from these findings that the ability of GFPN5 to trigger apoptotic cell death and inhibit clonogenicity correlates with its nuclear localization. Since amino acids 414 to 430 are not required for p84N5 function, as indicated by the GFPN5hNLS mutant, loss of function in the GFPN5-NLS protein is due to lack of nuclear localization rather than to disruption of a required functional domain. The GFPNLS fusion protein containing only the N5 NLS is localized to the nucleus but fails to function like GFPN5. This finding demonstrates that nuclear localization of GFP alone is insufficient for induction of apoptosis or inhibition of clonogenicity.
N5 protein can mediate apoptotic cell death and this ability requires an intact death domain located in the C-terminus of the protein (Doostzadeh-Cizeron et al., 1999) . In other apoptotic signaling pathways, the death domain specifies required protein interactions (Wolf and Green, 1999; Yuan, 1997) . To our knowledge the known death domain-containing proteins involved in apoptosis are not localized to the nucleus and function in signaling pathways originating outside the nucleus. The experiments described here identify p84N5 as a unique death domain-containing protein that functions within the nucleus to trigger apoptosis.
Interestingly, p84N5 associates with the nuclear Rb tumor suppressor protein and this association inhibits p84N5-induced apoptosis (Doostzadeh-Cizeron et al., 1999) . The p84N5 sequences required for Rb association overlap with its death domain (Durfee et al., 1994) . Rb, therefore, may inhibit p84N5-induced apoptosis by precluding required death domainmediated interactions between p84N5 and other apoptotic signaling molecules. Rb is known to inhibit apoptosis initiated from within the nucleus; for example Rb inhibits apoptosis triggered by ionizing radiation (Haas-Kogan et al., 1995) . The mechanisms used by Rb to inhibit apoptosis are not completely understood.
We hypothesize that p84N5 participates in an apoptotic signaling pathway initiated from within the nucleus that is regulated by Rb. Consistent with this hypothesis, p84N5-induced apoptosis has a pattern of Figure 4 Nuclear localization is required for p84N5-induced loss of clonogenic potential. SAOS-2 cells were seeded in 100-mm dishes at 25% confluency and transfected the following day using the calcium phosphate precipitation method as in Figure 1 using 12 mg of total DNA, including 2 mg of EGFP-C1 plasmid (Clontech, Palo Alto, CA, USA). The day after transfection, cells were examined for green fluorescent protein (GFP) by fluorescence microscopy and the number of GFP positive cells per randomly chosen 1006 fields of view were counted. Transfection efficiencies for independent assays ranged between 10 -15%, but transfection efficiencies among different plasmids within an experiment were not consistently different. Two days following transfection, cells were grown in the presence of 500 mg/ml G418 to select for successfully transfected cells. Two weeks later, the number of surviving GFPpositive colonies containing greater than 20 cells were counted in at least 50 randomly chosen 1006 fields of view using a fluorescence microscope. The surviving fraction was calculated by dividing the number of colonies per field of view by the number of GFP positive cells per field of view originally recorded one day after transfection. The data shown are the mean and standard deviation of at least three independent experiments for each plasmid caspase, NF-kB, and cell cycle checkpoint activation that is similar to that observed in response to some forms of DNA damage known to be regulated by Rb (Doostzadeh-Cizeron et al., 2000 , 2001 . Further, the amino-terminal domain of Rb is not only required to bind p84N5, but is also required to regulate the cell cycle and apoptotic responses of p53 null cells to ionizing radiation (BS Poe, unpublished) . The data presented in this study suggest that p84N5 is a good candidate for mediating some of Rb's inhibitory effects on apoptotic responses triggered by DNA damage.
Further, by analogy to other death domain-containing proteins, additional study of p84N5 may inform our understanding of the mechanisms involved in apoptotic signaling initiated within the nucleus.
